
Dapagliflozin 10 mg (Forxiga) is an oral medicine used to treat type 2 diabetes, heart failure, and chronic kidney disease (CKD) in eligible patients. It helps lower blood sugar levels, protects the heart and kidneys, and reduces the risk of disease-related complications when used alongside a healthy diet and lifestyle.
| Generic name | Dapagliflozin |
| Strength | 10 mg |
| Manufacturer | AstraZeneca |
| Package size | 98 Tablets |
| Used for | Type 2 diabetes, heart failure, and chronic kidney disease |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by blocking the SGLT2 protein in the kidneys, reducing glucose reabsorption and allowing excess sugar to be removed through the urine. This helps lower blood sugar levels while also providing benefits for heart and kidney health.
Dr. Unnati Mehra has professional experience supporting patients with diabetes and related metabolic conditions. She follows an individualised approach to blood glucose management that considers prescribed medicines, glucose readings, nutrition, physical activity and overall health.